AbCellera Biologics Inc. ABCL Accounts and accrued receivable
Accounts and accrued receivable at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:AccountsAndAccruedReceivableCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s accounts and accrued receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s accounts and accrued receivable?
- AbCellera Biologics Inc. (ABCL) reported accounts and accrued receivable of $36.76M in Q1 2026.
- How has AbCellera Biologics Inc.'s accounts and accrued receivable changed year-over-year?
- AbCellera Biologics Inc.'s accounts and accrued receivable decreased by 8.1% year-over-year, from $40.01M to $36.76M.
- What is the long-term trend for AbCellera Biologics Inc.'s accounts and accrued receivable?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s accounts and accrued receivable has grown at a -22.8% compound annual growth rate (CAGR), from $213.24M to $58.29M.
- What does accounts and accrued receivable mean?
- This represents the total amount owed to the company by customers for goods or services delivered, including both invoiced accounts receivable and accrued revenue for work performed but not yet billed. It serves as a key indicator of the company's short-term liquidity and the effectiveness of its revenue collection cycle. Monitoring this balance helps assess the risk of uncollectible accounts and the timing of cash inflows from operations.